Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial.
Lebbé C, Meyer N, Mortier L, Marquez-Rodas I, Robert C, Rutkowski P, Menzies AM, Eigentler T, Ascierto PA, Smylie M, Schadendorf D, Ajaz M, Svane IM, Gonzalez R, Rollin L, Lord-Bessen J, Saci A, Grigoryeva E, Pigozzo J. Lebbé C, et al. Among authors: grigoryeva e. J Clin Oncol. 2019 Apr 10;37(11):867-875. doi: 10.1200/JCO.18.01998. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811280 Free PMC article. Clinical Trial.
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).
Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Schadendorf D. Nathan P, et al. Among authors: grigoryeva e. Eur J Cancer. 2019 Sep;119:168-178. doi: 10.1016/j.ejca.2019.07.010. Epub 2019 Aug 21. Eur J Cancer. 2019. PMID: 31445199 Free article. Clinical Trial.
Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).
Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Nathan P. Schadendorf D, et al. Among authors: grigoryeva e. Eur J Cancer. 2019 Nov;121:144-153. doi: 10.1016/j.ejca.2019.08.014. Epub 2019 Sep 30. Eur J Cancer. 2019. PMID: 31581055 Clinical Trial.
Characterization of EpCAM-Positive and EpCAM-Negative Tumor Cells in Early-Stage Breast Cancer.
Perelmuter VM, Grigoryeva ES, Alifanov VV, Kalinchuk AY, Andryuhova ES, Savelieva OE, Patskan IA, Bragina OD, Garbukov EY, Vostrikova MA, Zavyalova MV, Denisov EV, Cherdyntseva NV, Tashireva LA. Perelmuter VM, et al. Among authors: grigoryeva es. Int J Mol Sci. 2024 Oct 16;25(20):11109. doi: 10.3390/ijms252011109. Int J Mol Sci. 2024. PMID: 39456890 Free PMC article.
Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries).
Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Batluk TI, Koziolova NA, Chesnikova AI, Vaskin AY, Tokmin DS, Bakulin IG, Barbarash OL, Grigoryeva NY, Gubareva IV, Izmozherova NV, Kamilova UK, Kechedzhieva SG, Kim ZF, Koriagina NA, Mironova SV, Mitkovskaya NP, Nemirova SV, Nurieva LM, Petrova MM, Polyanskaya EA, Rebrov AP, Svarovskaya AV, Smirnova EA, Sugraliev AB, Khovaeva YB, Shavkuta GV, Shaposhnik II, Alieva MYK, Almukhanova AB, Aparkina AV, Bashkinov RA, Belousova LN, Blokhina EI, Bochkareva VO, Buianova VM, Valikulova FY, Vende AD, Galyavich AS, Genkel VV, Gorbunova EV, Gordeychuk ED, Grigorenko EA, Grigoryeva EV, Davydkin IL, Evdokimov DS, Ermilova AN, Zhangelova SB, Zhdankina NV, Zheleznyak EI, Ilyanok NS, Kapsultanova DA, Karoli NA, Kartashova EA, Kuznetsova AS, Kumaritova AT, Magdeeva NA, Makarov SA, Melnikov ES, Novikova MV, Obukhova IA, Ponomarenko EV, Rubanenko AO, Rubanenko OA, Rustamova FE, Safronenko VA, Suchkova EI, Sycheva AI, Tagaeva DR, Trubnikova MA, Trunina TP, Frolov AG, Khatlamadzhiyan VV, Khokhlova YI, Chernyavina AI, Chizhova OY, Shambatov MAO, Shnyukova TV, Shchukin YV. Arutyunov GP, et al. Among authors: grigoryeva ev. Kardiologiia. 2024 Aug 31;64(8):13-23. doi: 10.18087/cardio.2024.8.n2683. Kardiologiia. 2024. PMID: 39262349 English, Russian.
EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.
Perelmuter VM, Grigoryeva ES, Savelieva OE, Alifanov VV, Andruhova ES, Zavyalova MV, Bragina OD, Garbukov EY, Menyailo ME, Khozyainova AA, Denisov EV, Cherdyntseva NV, Tashireva LA. Perelmuter VM, et al. Among authors: grigoryeva es. Sci Rep. 2024 May 28;14(1):12245. doi: 10.1038/s41598-024-61516-2. Sci Rep. 2024. PMID: 38806508 Free PMC article.
67 results